SEC Filings

10-K
ARRAY BIOPHARMA INC filed this Form 10-K on 08/11/2017
Entire Document
 

 
 
 
 
 
 
Supplemental disclosure of cash flow information
 
 
 
 
 
Cash paid for interest
$
4,386

 
$
4,466

 
$
4,450

Change in unrealized gain on marketable securities
$
(83
)
 
$
2

 
$
3

 
 
 
 
 
 

The accompanying notes are an integral part of these financial statements.

F-9